POSPÍŠILOVÁ, Dagmar, D. HOLUB, Z. ZIDOVA, L. SULOVSKA, J. HOUDA, V. MIHAL, I. HADACOVA, Lenka RADOVÁ, P. DZUBAK, Marian HAJDÚCH, Vladimír DIVOKÝ and M. HORVATHOVA. Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency. Haematologica. PAVIA: FERRATA STORTI FOUNDATION, 2014, vol. 99, No 7, p. 118-121. ISSN 0390-6078. Available from: https://dx.doi.org/10.3324/haematol.2014.104034.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency
Authors POSPÍŠILOVÁ, Dagmar (203 Czech Republic), D. HOLUB (203 Czech Republic), Z. ZIDOVA (203 Czech Republic), L. SULOVSKA (203 Czech Republic), J. HOUDA (203 Czech Republic), V. MIHAL (203 Czech Republic), I. HADACOVA (203 Czech Republic), Lenka RADOVÁ (203 Czech Republic, guarantor, belonging to the institution), P. DZUBAK (203 Czech Republic), Marian HAJDÚCH (203 Czech Republic), Vladimír DIVOKÝ (203 Czech Republic) and M. HORVATHOVA (203 Czech Republic).
Edition Haematologica, PAVIA, FERRATA STORTI FOUNDATION, 2014, 0390-6078.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Italy
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.814
RIV identification code RIV/00216224:14740/14:00078458
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.3324/haematol.2014.104034
UT WoS 000342833500008
Keywords in English Diamond Blackfan anemia; hepcidin levels; erythropoietic activity; transfusion dependency
Tags kontrola MP, rivok
Tags International impact, Reviewed
Changed by Changed by: Martina Prášilová, učo 342282. Changed: 6/3/2015 09:04.
Abstract
Diamond-Blackfan anemia (DBA) is a rare congenital red cell aplasia associated with mutations in ribosomal proteins (RP) in 49-71% of cases.1 DBA is a clinically heterogeneous disorder with one-third of patients developing transfusion-acquired iron overload.2 The severity of anemia and transfusion dependency in DBA is comparable to transfusiondependent beta-thalassemia major; however, moderate to severe suppression of erythropoiesis in DBA2 is in contrast to accelerated ineffective erythropoiesis in beta-thalassemia.3,4 The knowledge of systemic iron regulation in DBA is limited.
Links
306242, interní kód MUName: NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (Acronym: NGS-PTL)
Investor: European Union, Cooperation
PrintDisplayed: 26/4/2024 05:58